The financial terms of the deal were not disclosed. GE Healthcare expects to close the deal in January 2021; its held a minority position in the company since 2017.
Photon-counting CT technology, according to GE Healthcare, could expand the clinical capabilities of traditional CT — providing diagnostic benefits in clinical areas including oncology, cardiology and neurology.